Lv41
799 积分 2020-07-05 加入
The Role of Permeability in Drug ADME/PK, Interactions and Toxicity—Presentation of a Permeability-Based Classification System (PCS) for Prediction of ADME/PK in Humans
8分钟前
已完结
BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis
22天前
已完结
Inhibition of MDR3 Activity in Human Hepatocytes by Drugs Associated with Liver Injury
22天前
已完结
DILIsym: Quantitative systems toxicology impacting drug development
26天前
已完结
A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups
26天前
已完结
Use of Structural Alerts for Reactive Metabolites in the Application SpotRM
1个月前
已完结
Delivering on the promise of protein degraders
1个月前
已完结
Preclinical translational physiologically based pharmacokinetic modeling for predicting human pharmacokinetics of proteolysis targeting chimeras: Case studies of vepdegestrant (ARV-471) and bavdegalutamide (ARV-110)
1个月前
已完结
Chapter 4. Developing Pharmacokinetic/Pharmacodynamic Relationships With PROTACs
1个月前
已完结
Effects of intestinal permeation enhancers on solubilization and epithelial transport of the proteolysis targeting chimera (PROTAC) ARV-471 in rats
2个月前
已关闭